Cargando…
Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475410/ https://www.ncbi.nlm.nih.gov/pubmed/32953711 http://dx.doi.org/10.21037/atm-2020-34 |
| _version_ | 1783579498636115968 |
|---|---|
| author | Luna, Carlos M. Perín, María M. |
| author_facet | Luna, Carlos M. Perín, María M. |
| author_sort | Luna, Carlos M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7475410 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74754102020-09-17 Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant? Luna, Carlos M. Perín, María M. Ann Transl Med Editorial AME Publishing Company 2020-08 /pmc/articles/PMC7475410/ /pubmed/32953711 http://dx.doi.org/10.21037/atm-2020-34 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Luna, Carlos M. Perín, María M. Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant? |
| title | Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant? |
| title_full | Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant? |
| title_fullStr | Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant? |
| title_full_unstemmed | Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant? |
| title_short | Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant? |
| title_sort | can lactate dehydrogenase (ldh) be used as a marker of severity of pneumonia in patients with renal transplant? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475410/ https://www.ncbi.nlm.nih.gov/pubmed/32953711 http://dx.doi.org/10.21037/atm-2020-34 |
| work_keys_str_mv | AT lunacarlosm canlactatedehydrogenaseldhbeusedasamarkerofseverityofpneumoniainpatientswithrenaltransplant AT perinmariam canlactatedehydrogenaseldhbeusedasamarkerofseverityofpneumoniainpatientswithrenaltransplant |